Canaccord analyst Joseph Vafi lowered the firm’s price target on Strategy (MSTR) to $409 from $510 and keeps a Buy rating on the shares. The firm said the company’s 2025 setup is continuing to ...
Barclays lowered the firm’s price target on Strategy (MSTR) to $421 from $515 and keeps an Overweight rating on the shares. The firm updated the company’s model post the earnings report.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果